<DOC>
	<DOCNO>NCT01954524</DOCNO>
	<brief_summary>Safety tolerability single dose intravenous bolus injection Sildenafil patient moderate severe cirrhosis kidney disease determine .</brief_summary>
	<brief_title>A Phase 1 , Open-Label Study Intravenous Sildenafil Patients With Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Subjects eligible study meet follow inclusion criterion : 1 . Cirrhosis . Diagnosis cirrhosis base either liver biopsy OR clinical characteristic ( e.g . history ascites encephalopathy esophageal varix gastric varix splenomegaly spider angioma clinical sign portal hypertension/cirrhosis ) , laboratory ( e.g . history thrombocytopenia history APRI ( Reference : Wai CT , Greenson JK , Fontana RJ , Kalbfleisch JD , Marrero JA , Conjeevaram HS , Lok AS . A simple noninvasive index predict significant fibrosis cirrhosis patient chronic hepatitis C. Hepatology 2003 ; 38:51826 ) [ Aspartate aminotransferase ( AST ) platelet ratio index ] score consistent cirrhosis history abnormal liver function test ) abdominal imaging ( Magnetic Resonance Imaging Computed Tomography ultrasound abdomen ) data 2 . CTP Class B C cirrhosis 3 . Age 18 year old time enrollment 4 . Variceal screen upper endoscopy within 1 year enrollment 5 . Renal dysfunction [ GFR ≥ 15 &lt; 60 ml/min/1.73m2 estimate 6variable MDRD equation ( Reference : Levey AS , Coresh J , Greene T , Stevens LA , Zhang YL , Hendriksen S , Kusek JW , Van Lente F. Using standardize serum creatinine value modification diet renal disease study equation estimate glomerular filtration rate . Ann Intern Med 2006 ; 145:24754 ) ] 6 . Hemoglobin level ≥ 8 mg/dl within 4 week enrollment 7 . Serum sodium level ≥ 125 mmol/L within 4 week enrollment Subjects exclude follow : 1 . Inability provide inform consent 2 . Women pregnant , breastfeeding , contemplate pregnancy 3 . Treatment organic nitrate , ritonavir , erythromycin , saquinavir , ketoconazole , itraconazole , cimetidine , bosentan , rifampin , Sildenafil PDE5 inhibitor , alphablockers , anticoagulant within 7 day enrollment 4 . Hypersensitivity allergy Sildenafil component Sildenafil 5 . Previous reaction PDE5 inhibitor include , limited Sildenafil , Vardenafil , Tadalafil , Avanafil ( Myocardial infarction , ventricular arrhythmia , sudden cardiac death , cerebrovascular hemorrhage , transient ischemic attack , stroke , transient global amnesia , subarachnoid intracerebral hemorrhage , seizure , recurrence seizure , pulmonary hemorrhage , sudden decrease hearing , loss hearing , anxiety , prolonged erection , priapism , ocular redness , ocular burning , diplopia , temporary vision loss/decreased vision , ocular swelling , ocular pressure , increase intraocular pressure , retinal problem eye , vitreous detachment , vitreous traction , paramacular edema , nonarteritic anterior ischemic optic neuropathy ) 6 . History untreated severe leave ventricular outflow obstruction ( e.g . aortic stenosis , idiopathic hypertrophic subaortic stenosis ) 7 . History pulmonary venoocclusive disease 8 . History unstable angina , myocardial infarctus , lifethreatening arrhythmia stroke within 6 month enrollment 9 . History retinitis pigmentosa 10 . Anatomical deformation penis ( Peyronie 's disease , angulation , cavernosal fibrosis ) 11 . History sickle cell anemia , multiple myeloma leukemia 12 . Renal failure treat dialysis 13 . Cognitive impairment base IRB `` evaluation sign consent form '' 14 . Transjugular intrahepatic portosystemic shunt placement 15 . Previous kidney liver transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>